Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Gregson

Showing results (101-110 of 113) with videos related to

Pageof 12
Sort By:
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|March 9, 2021
Cardiovascular magnetic resonance predictors of heart failure in hypertrophic cardiomyopathy: the role of myocardial replacement fibrosis and the microcirculationClaire E Raphael, Frances Mitchell, Gajen Sunthar Kanaganayagam, et al.
Lancet (London, England)|November 16, 2018
Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trialBrian P Halliday, Rebecca Wassall, Amrit S Lota, et al.
The Lancet. Neurology|April 19, 2025
Optimised medical therapy alone versus optimised medical therapy plus revascularisation for asymptomatic or low-to-intermediate risk symptomatic carotid stenosis (ECST-2): 2-year interim results of a multicentre randomised trialSimone J A Donners, Twan J van Velzen, Suk Fun Cheng, et al.
The Lancet. Infectious Diseases|December 5, 2017
HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysisRavindra K Gupta, John Gregson, Neil Parkin, et al.
Journal of the American College of Cardiology|September 18, 2020
Trial Design Principles for Patients at High Bleeding Risk Undergoing PCI: JACC Scientific Expert PanelDavide Capodanno, Marie-Claude Morice, Dominick J Angiolillo, et al.
Circulation|May 23, 2019
Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary InterventionPhilip Urban, Roxana Mehran, Roisin Colleran, et al.
European Heart Journal|May 23, 2019
Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding RiskPhilip Urban, Roxana Mehran, Roisin Colleran, et al.
Journal of the American College of Cardiology|June 2, 2022
Precision Phenotyping of Dilated Cardiomyopathy Using Multidimensional DataUpasana Tayal, Job A J Verdonschot, Mark R Hazebroek, et al.
The New England Journal of Medicine|September 29, 2019
Five-Year Outcomes after PCI or CABG for Left Main Coronary DiseaseGregg W Stone, A Pieter Kappetein, Joseph F Sabik, et al.
Circulation|September 26, 2022
Genetic Architecture of Acute Myocarditis and the Overlap With Inherited CardiomyopathyAmrit S Lota, Mark R Hazebroek, Pantazis Theotokis, et al.
Pageof 12

Showing results (101-110 of 113) with videos related to

Sort By:
Pageof 12
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|March 9, 2021
Cardiovascular magnetic resonance predictors of heart failure in hypertrophic cardiomyopathy: the role of myocardial replacement fibrosis and the microcirculationClaire E Raphael, Frances Mitchell, Gajen Sunthar Kanaganayagam, et al.
Lancet (London, England)|November 16, 2018
Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trialBrian P Halliday, Rebecca Wassall, Amrit S Lota, et al.
The Lancet. Neurology|April 19, 2025
Optimised medical therapy alone versus optimised medical therapy plus revascularisation for asymptomatic or low-to-intermediate risk symptomatic carotid stenosis (ECST-2): 2-year interim results of a multicentre randomised trialSimone J A Donners, Twan J van Velzen, Suk Fun Cheng, et al.
The Lancet. Infectious Diseases|December 5, 2017
HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysisRavindra K Gupta, John Gregson, Neil Parkin, et al.
Journal of the American College of Cardiology|September 18, 2020
Trial Design Principles for Patients at High Bleeding Risk Undergoing PCI: JACC Scientific Expert PanelDavide Capodanno, Marie-Claude Morice, Dominick J Angiolillo, et al.
Circulation|May 23, 2019
Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary InterventionPhilip Urban, Roxana Mehran, Roisin Colleran, et al.
European Heart Journal|May 23, 2019
Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding RiskPhilip Urban, Roxana Mehran, Roisin Colleran, et al.
Journal of the American College of Cardiology|June 2, 2022
Precision Phenotyping of Dilated Cardiomyopathy Using Multidimensional DataUpasana Tayal, Job A J Verdonschot, Mark R Hazebroek, et al.
The New England Journal of Medicine|September 29, 2019
Five-Year Outcomes after PCI or CABG for Left Main Coronary DiseaseGregg W Stone, A Pieter Kappetein, Joseph F Sabik, et al.
Circulation|September 26, 2022
Genetic Architecture of Acute Myocarditis and the Overlap With Inherited CardiomyopathyAmrit S Lota, Mark R Hazebroek, Pantazis Theotokis, et al.
Pageof 12